Wai Yuen Tong Medicine Holdings Limited (0897.HK)
HKD 0.21
(-0.48%)
HKD 0.21
(-0.48%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 191.68 Million | 91.57 Million | 116.18 Million | 358.49 Million | 9.17 Million | -26.63 Million |
| Net Income | 49.68 Million | -20.51 Million | -108.91 Million | -375.99 Million | 438.54 Million | 74.62 Million |
| Depreciation & Amortization | 111.15 Million | 113.04 Million | 107.79 Million | 92.62 Million | 112.67 Million | 51.32 Million |
| Deferred income taxes | - | -152.98 Million | 84.07 Million | - | - | - |
| Stock-based compensation | 3.83 Million | 4.64 Million | 1.13 Million | - | - | - |
| Change in working capital | -86.97 Million | -32.87 Million | -75.38 Million | 299.69 Million | -47.41 Million | 29.69 Million |
| Other non-cash items | 104.09 Million | 180.25 Million | 107.46 Million | 342.16 Million | -494.62 Million | -182.27 Million |
| Investing Cash Flow | -84.62 Million | 15.06 Million | -15.9 Million | -81.78 Million | 337.65 Million | -102.88 Million |
| Investments in PPE | -34.64 Million | -33.44 Million | -26.03 Million | -59.5 Million | -6.8 Million | -16.97 Million |
| Acquisitions | -150.84 Million | 49.25 Million | 883 Thousand | 4.24 Million | 173.17 Million | -311.66 Million |
| Investment purchases | -40.67 Million | -115.46 Million | -149.16 Million | -134.23 Million | -482.36 Million | -199.47 Million |
| Sales/Maturities of investments | 109.93 Million | 112.9 Million | 161.8 Million | 111.65 Million | 653.65 Million | 220 Million |
| Other Investing Activities | 6.1 Million | 1.81 Million | -3.39 Million | -3.94 Million | 754 Thousand | 205.21 Million |
| Financing Cash Flow | -469.96 Million | -67.25 Million | -115.26 Million | -266.48 Million | -36.49 Million | -113.29 Million |
| Debt repayment | -233.36 Million | -6.1 Million | -25.29 Million | -204.11 Million | -28.78 Million | -264.79 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -14.72 Million | -9.96 Million | - | - | - | -9.95 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -12.3 Million | -51.18 Million | -89.97 Million | -62.36 Million | -7.71 Million | 161.44 Million |
| Accounts receivables | -13.13 Million | -14 Million | -14.42 Million | 16.49 Million | 19.88 Million | 17.48 Million |
| Accounts payables | -2.29 Million | -3.14 Million | 12.2 Million | 1.68 Million | -17.18 Million | -24.69 Million |
| Inventory | -45.96 Million | 94.9 Million | 303.02 Million | 126.07 Million | -15.47 Million | 12.21 Million |
| Other working capital | -25.58 Million | -110.63 Million | -376.18 Million | 155.44 Million | -34.64 Million | 24.69 Million |
| Cash at beginning of period | 526.7 Million | 548.7 Million | 529.53 Million | 483.85 Million | 171.2 Million | 420.84 Million |
| Cash at end of period | 154.96 Million | 571.53 Million | 548.7 Million | 529.53 Million | 483.85 Million | 171.2 Million |
| Capital Expenditure | -34.64 Million | -33.44 Million | -26.03 Million | -59.5 Million | -6.8 Million | -16.97 Million |
| Effect of forex changes on cash | -8.83 Million | -12.11 Million | 31.75 Million | 34.34 Million | -6.59 Million | -6.82 Million |
| Net cash flow / Change in cash | -371.73 Million | 22.83 Million | 19.17 Million | 45.67 Million | 312.65 Million | -249.64 Million |
| Free Cash Flow | 157.03 Million | 58.13 Million | 90.14 Million | 298.98 Million | 2.37 Million | -43.6 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.22 Million | 49.68 Million | 3.54 Million | -20.51 Million | 32.86 Million | -53.38 Million |
| Depreciation & Amortization | 34.58 Million | 111.15 Million | 54.59 Million | 113.04 Million | 56.55 Million | 56.49 Million |
| Deferred income taxes | - | - | - | -152.98 Million | -198.66 Million | - |
| Stock-based compensation | - | 3.83 Million | - | 4.64 Million | 4.64 Million | - |
| Change in working capital | - | -86.97 Million | - | -32.87 Million | 13.87 Million | - |
| Other non-cash items | 137.39 Million | 104.09 Million | 78.61 Million | 180.25 Million | 157.59 Million | 67.54 Million |
| Investing Cash Flow | -246.83 Million | -84.62 Million | 107.81 Million | 15.06 Million | -26.27 Million | 41.34 Million |
| Investments in PPE | 9.78 Million | -34.64 Million | -44.43 Million | -33.44 Million | -14.9 Million | -18.54 Million |
| Acquisitions | -196.5 Million | -150.84 Million | 132.48 Million | 49.25 Million | 49.07 Million | 176 Thousand |
| Investment purchases | -13.17 Million | -40.67 Million | -35.39 Million | -115.46 Million | -88.73 Million | -26.72 Million |
| Sales/Maturities of investments | 59.56 Million | 109.93 Million | 50.37 Million | 112.9 Million | 25.39 Million | 87.51 Million |
| Other Investing Activities | -106.49 Million | 6.1 Million | 4.78 Million | 1.81 Million | 2.89 Million | -1.07 Million |
| Financing Cash Flow | -149.9 Million | -469.96 Million | -169.09 Million | -67.25 Million | -184.03 Million | 116.78 Million |
| Debt repayment | -135.74 Million | -233.36 Million | -97.61 Million | -6.1 Million | -132.37 Million | -138.47 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -14.72 Million | -14.72 Million | -9.96 Million | - | -9.96 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 20.53 Million | -12.3 Million | -27.11 Million | -51.18 Million | -21.3 Million | 16 Million |
| Accounts receivables | - | -13.13 Million | - | -14 Million | -14 Million | - |
| Accounts payables | - | -2.29 Million | - | -3.14 Million | - | - |
| Inventory | - | -45.96 Million | - | 94.9 Million | 94.9 Million | - |
| Other working capital | - | -25.58 Million | - | -110.63 Million | -67.03 Million | - |
| Cash at beginning of period | 456 Million | 526.7 Million | 571.53 Million | 548.7 Million | 606.29 Million | 548.7 Million |
| Cash at end of period | 159.41 Million | 154.96 Million | 519.65 Million | 571.53 Million | 571.53 Million | 606.29 Million |
| Capital Expenditure | 9.78 Million | -34.64 Million | -44.43 Million | -33.44 Million | -14.9 Million | -18.54 Million |
| Effect of forex changes on cash | - | -8.83 Million | -36.15 Million | -12.11 Million | 28.86 Million | -40.98 Million |
| Net cash flow / Change in cash | -296.58 Million | -371.73 Million | -51.88 Million | 22.83 Million | -34.75 Million | 57.58 Million |
| Free Cash Flow | 82.37 Million | 157.03 Million | -16.86 Million | 58.13 Million | 119 Million | -60.87 Million |
600682
CWSRF
TRVR
FXG
DIAMONDYD
EIMCOELECO